Acadia Pharmaceuticals
Christopher Biwald is a seasoned professional in the field of analytical chemistry with over 35 years of experience in the pharmaceutical industry. Currently, as Senior Director of GMP Quality Control at ACADIA Pharmaceuticals Inc., Christopher oversees quality assurance for analytical methods and specifications related to product testing and release. Prior experience includes Director of Quality Systems at Ohr Pharmaceutical Inc., where responsibilities involved developing quality systems and guiding the validation of analytical test methods. Christopher also held the position of Associate Director at Amylin Pharmaceuticals, managing Analytical Research and Development, and served as a Senior Development Scientist at Ligand Pharmaceuticals, focusing on analytical method validation. Early career roles include Research Investigator at Calgon Vestal and Group Leader at Sigma Chemical, where Christopher contributed to method development and compliance with regulatory standards. Christopher holds a master's degree in analytical chemistry from Saint Louis University.
This person is not in any teams
This person is not in any offices
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.